Author

M. Badr

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. Arenas-Pinto· 1 shared A. G. Schatzlein· 1 shared A. Milewska· 1 shared D. Fernandez-Reyes· 1 shared E. B. Duran· 1 shared I. F. Uchegbu· 1 shared K. Pyrc· 1 shared P. Botwina· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. Arenas-Pinto

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

SARS-CoV-2 inhibition in human airway epithelial cells using a mucoadhesive, amphiphilic chitosan that may serve as an anti-viral nasal spray

K. Pyrc, A. Milewska, E. B. Duran, P. Botwina, R. Lopes, A. Arenas-Pinto, M. Badr, R. Mellor, T. Kalber, D. Fernandez-Reyes, A. G. Schatzlein, I. F. Uchegbu

This paper demonstrates that GCPQ, a mucoadhesive chitosan derivative, reduces SARS-CoV-2 infectivity in cell cultures and shows promising nasal retention in mice, supporting its potential as a nasal spray for COVID-19 prevention.

bioRxiv · Dec 10, 2020 · PreprintPharmacology & Toxicology